MeSH D004942 - peptic esophagitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Salix Pharmaceuticals | Famotidine | Pepcid |  | 1987-02-02 |  |  |
| Teva | Famotidine | Famotidine |  | 2001-04-16 |  |  |
| Famotidine, Ibuprofen | Ibuprofen Famotidine |  | 2021-10-29 |  |  | |
| Ranitidine | Ranitidine |  | 2003-10-31 |  |  | |
| Taro Pharmaceutical | Ranitidine | Ranitidine |  | 2011-06-13 |  |  |
| Glenmark Pharmaceuticals | Famotidine | Famotidine |  | 2005-03-07 |  |  |
| Nizatidine | Nizatidine |  | 2011-07-15 |  |  | |
| Ranitidine | Ranitidine |  | 2008-11-19 |  |  | |
| Mylan | Famotidine | Famotidine |  | 2001-04-18 |  |  |
| Nizatidine | Nizatidine |  | 2002-07-05 |  |  | |
| Ranitidine | Ranitidine |  | 1997-08-22 |  |  | |
| Dexlansoprazole | Dexlansoprazole |  | 2024-01-19 |  |  | |
| NATCO Pharma | Famotidine | Famotidine |  | 2001-12-21 |  |  |
| Johnson & Johnson | Famotidine | Pepcid Ac |  | 1995-04-28 |  |  |
| Famotidine | Pepcid Complete |  | 2000-10-16 |  |  | |
| Perrigo | Famotidine | Famotidine |  | 2005-03-18 |  |  |
| Famotidine | Famotidine, Carbonate, Magnesium Hydroxide |  | 2008-02-06 |  |  | |
| Ranitidine | Ranitidine |  | 2002-08-30 |  |  | |
| P&L Developments (PLD) | Famotidine | Famotidine |  | 2001-07-26 |  |  |
| GSK | Nizatidine | Axid Ar |  | 1996-05-09 |  |  |
| Ranitidine | Zantac |  | 1983-06-09 |  |  | |
| Ranitidine | Tritec |  | 1996-08-08 |  |  |
1
2
3
4
5
6
...
8
>
Clinical Trials
Historical Success Rate
Phase 1
50%1/2
Phase 2
86%6/7
Phase 3
85%11/13
Approved: 6Overall Success rate: 36%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use